TEAM

We develop and make available new compounds for the treatment of viral infections, which are innovative in terms of approach

Prof. Santo Landolfo

Prof. Santo Landolfo

MD. R&D supervisor, Legal representative, Responsible for communication

Curriculum Vitae

He is Full Professor of Microbiology and Clinical Microbiology at the University of Turin, School of Medicine. He has been Director of the Immunogenetics and Experimental Oncology Center, National Research Council, Turin. He has published over 260 scientific papers in the areas of Interferons, Viral Infections and Autoimmunity. In 2003 he has been awarded by the Italian National Academy of Sciences, Rome, Italy, for the studies on the role of Interferon inducible genes in the resistance against Cytomegalovirus Infections. He is a Fellow of the American Society of Microbiology, European Society of Virology, International Cytokine and Interferon Society, and Italian Society of Microbiology. He has been founder and owner of the academic spin-off Notopharm Srl, and involved in the startup phase of two other academic spin-offs. He is inventor of more than 10 international patents. He regularly serves on grant review boards and advisory panels at Italian Minister for University and Research.

Prof. Marco De Andrea

Prof. Marco De Andrea

MD, PhD. CTO, Laboratory coordinator, Responsible for biomaterials

marco.deandrea@notovir.it

Curriculum Vitae

He is Associate Professor of Microbiology and Clinical Microbiology at the University of Turin, School of Medicine. He received his degree in Biology in 1996 from the University of Turin – Italy, where he also completed his PhD program in Immunology. He received his Medical degree in 2008 from the University of Piemonte Orientale, Novara – Italy. He is member of the European Society of Virology, International Cytokine and Interferon Society, European Crohn’s and Colitis European Organisation – ECCO, and Italian Society of Microbiology. His research interests are on the role of Interferon inducible genes in the resistance against Cytomegalovirus Infections, on intrinsic immunity to viral and bacterial infections, and on the role of AIM2-like sensors in the pathogenesis of autoimmune diseases. He is an active member of the Translational Center for Autoimmune and Allergic Disease – CAAD at University of Piemonte Orientale, Novara – Italy. He is author of more than 70 scientific papers on international peer-reviewed journals, with topics related to viral infections and autoimmunity. He is inventor of two international patents.

Prof. Marisa Gariglio

Prof. Marisa Gariglio

MD, PhD. CEO, Laboratory coordinator, Responsible for clinical development

Curriculum Vitae

She received her degree in Biology in 1984 and her Medical degree in 1990 from the University of Turin – Italy, where she also completed her PhD program in Immunology and Microbiology. After post-doctoral training at the Department of Molecular Biology “Hoffmann La Roche” (Basel-Switzerland) studying transcriptional regulation of interferon-inducible genes, she joined the Novara Medical School in 1995 as Assistant Professor of Medical Microbiology. Since 2001, she is Full Professor and P.I. of the laboratory of Molecular Virology. She is director of the PhD Programme in Medical Sciences and Biotechnology at the University of Piemonte Orientale, Novara Medical School. She is author of more than 100 scientific papers on international peer-reviewed journals. Her major research interest is on Papillomavirus, Polyomavirus and virus-host interaction, especially on the role of IFI16 in modulating pathogen-mediated inflammation and autoimmunity. She is board member of the Translational Center for Autoimmune and Allergic Disease – CAAD at University of Piemonte Orientale, Novara – Italy. She was founder and owner of the academic spin-off Notopharm Srl, and inventor of three international patents.

Dr. Gloria Griffante

Dr. Gloria Griffante

- Responsible for biochemical character-rization and in vivo infection models (PhD Student in Molecular Medicine, University of Turin, Italy)

Dr. Matteo Biolatti

Dr. Matteo Biolatti

Lab Coordinator, Responsible for in vitro infection models (Assistant Professor of Medical Microbiology, University of Turin, Italy)

NoToVir S.r.l.s.  

Via Amico Canobio 4/6, 28100 Novara

P.IVA – 02543980037

info@notovir.it

Informativa cookies

1 + 15 =